PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 14, 20260 citationsOpen Access

Engineering high-titer lentiviral vectors for robust expression of RNA-based gene circuits

View Full Paper
KLKasey S. LoveBLBrittany A Lende-DornKGKate E. Galloway

Key Points

Key points are not available for this paper at this time.

Abstract

Lentiviral vectors enable efficient delivery of genetic cargoes for gene and cell therapies. With their ∼10-kb packaging limit, lentiviral vectors can encode multiple transcription units, supporting delivery of compact gene circuits. RNA-based devices offer highly compact control including ligand-responsive induction and closed-loop regulation. However, RNA devices such as ribozymes and splicing switches may interfere with vector production via activity on the single-stranded RNA genome. Here, we examine the impact of gene syntax and genetic parts to define design strategies for two-gene vectors encoding RNA devices. We find that titer decreases with genetic parts that interfere with transcription or processing of the viral transcript during production. Compared to initial vectors, our best-performing design boosts titer more than 30-fold, enabling fine-scale tuning of expression to optimize cell-fate conversion within a nonmonotonic landscape. Together, this work illuminates principles for constructing two-gene lentiviral vectors with both high titer and robust expression, enhancing efficacy for downstream applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Love et al. (2026) studied this question.

synapsesocial.com/papers/6a193dc0b71d9c859388cb2ehttps://doi.org/10.64898/2026.05.12.724401
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Limiting Transactivator Amounts Contribute to Transgene Mosaicism in Tet-On All-in-One Systems2022 · 9 citations
  2. 2Multidimensional control of therapeutic human cell function with synthetic gene circuits2022 · 162 citations
  3. 3Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems2010 · 268 citations
  4. 4Programmable promoter editing for precise control of transgene expression2025 · 11 citations
  5. 5Small-Molecule Aptamer for Regulating RNA Functions in Mammalian Cells and Animals2023 · 58 citations